OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)

Institutional investor profile sourced from SEC Form 13F-HR filings, parsed and aggregated by FilingIQ.

Total AUM
$2.45B
13F filings
191
Latest filing
May 15, 2026

Top 10 holdings

CMA $287.91M
11.77% of AUM
CDAY $283.33M
11.58% of AUM
RNA $268.08M
10.96% of AUM
NFC.U $262.74M
10.74% of AUM
AL $195.22M
7.98% of AUM
HOLX $194.05M
7.93% of AUM
EXAS $180.70M
7.39% of AUM
CADE $124.96M
5.11% of AUM
CFLT $120.07M
4.91% of AUM
SEE $49.54M
2.03% of AUM

About this filer

FilingIQ has indexed 191 quarterly Form 13F filings from OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC). Reported assets under management total $2.45B.

View live OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) filings on FilingIQ Raw 13F on SEC EDGAR

Frequently asked

How much does OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) have under management?
Per OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)'s most recent SEC Form 13F filing dated May 15, 2026, total assets under management are $2.45B. 13F filings cover long-only equity positions above the SEC reporting threshold.
How many 13F filings has OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) submitted?
FilingIQ has indexed 191 quarterly Form 13F filings from OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC). Filings are due 45 days after quarter-end.
Where does OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)'s holdings data come from?
Every position shown on this page sources back to OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)'s public SEC Form 13F-HR filing. The raw filing is on EDGAR at the link below. FilingIQ normalizes ticker mapping and computes percent-of-AUM at filing date.

Methodology & sources

All 13F data parsed from public SEC Form 13F-HR XML filings. AUM is the sum of reported position values at filing date. See methodology. Compiled by Thomas Kraaibeek. Not investment advice; see disclaimer.